Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multifunctional ROCO family signaling regulator 1 (MFHAS1) is a **probable GTP-binding protein** that plays regulatory roles in innate immunity, particularly by modulating **Toll-like receptor (TLR2 and TLR4) signaling pathways**, impacting inflammatory responses[1][11]. MFHAS1 can both inhibit and activate immune pathways: it negatively regulates TLR4-driven AP-1 activation by controlling phosphatase complex localization and positively modulates TLR2-dependent pro-inflammatory signaling, especially via p38/JNK MAP kinase activation[1][8][11]. It is also implicated in erythrocyte development and may play a role in inflammation induced by high glucose through AKT signaling[1]. MFHAS1 harbors structural features such as an ATP/GTP-binding site, leucine zippers, and leucine-rich repeats[1]. It has been described as a potential oncogene, especially in tumors with 8p amplification such as certain malignant fibrous histiocytomas, but there is no current evidence for therapeutic targeting with specific drugs or its use as a clinical biomarker[1][6][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multifunctional ROCO family signaling regulator 1 (MFHAS1).